07/14/2025
8:27 PM | Cavalier Jason (Reporting)
Lyra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
8:27 PM | Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
9:41 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
8:20 AM | Lyra Therapeutics (Filer)
| Form 424B5 | |
06/23/2025
6:00 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:00 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
6:22 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
2:41 PM | Lyra Therapeutics (Subject)
Waksal Harlan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
2:44 PM | Lyra Therapeutics (Subject)
Palasis Maria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2025
7:59 AM | Lyra Therapeutics (Filer)
| Form DEF 14A | |
04/04/2025
8:01 AM | Lyra Therapeutics (Filer)
| Form DEFA14A | |
03/25/2025
3:30 PM | Lyra Therapeutics (Filer)
| Form PRE 14A | |
02/14/2025
5:22 PM | CITADEL ADVISORS LLC (Filed by)
Lyra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
8:02 PM | Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/13/2024
4:06 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
5:39 PM | Lyra Therapeutics (Issuer)
Waksal Harlan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:54 PM | Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:48 PM | Lyra Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:48 PM | Lyra Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:49 PM | Lyra Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:53 PM | Lyra Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/15/2024
5:31 PM | Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
07/23/2024
3:05 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free LYRA Stock Alerts